Related Experiment Videos
[Laparoscopic surgery in adhesive disease]
Khirurgiia
|June 24, 2004
Summary
Laparoscopic surgery can cause viscero-parietal commissures (VPC), leading to complications in 76.7% of patients. Early detection via ultrasound and laparoscopic adhesiolysis offer effective treatment, with 87.2% success rates.
Area of Science:
- Gastroenterology
- Surgical Innovation
- Medical Diagnostics
Background:
- Adhesions, or viscero-parietal commissures (VPC), are a common complication following conventional and minimally invasive surgeries.
- These adhesions can lead to significant intraoperative difficulties and complications in subsequent procedures.
- Understanding the patterns of adhesion formation is crucial for improving patient outcomes.
Purpose of the Study:
- To analyze the incidence and characteristics of viscero-parietal commissures (VPC) after laparoscopic surgeries.
- To evaluate the diagnostic efficacy of specialized ultrasonic examinations for detecting VPC.
- To assess the success rate of laparoscopic adhesiolysis in treating adhesive disease and the use of Interceed (TC-7) in preventing recurrence.
Main Methods:
- Analysis of data from 2277 laparoscopic surgeries in patients with prior surgical history.
- Determination of adhesion formation patterns.
- Evaluation of diagnostic value of specialized ultrasonic examination.
- Assessment of outcomes for 195 laparoscopic adhesiolysis procedures.
- Application of Interceed (TC-7) in 14 patients to prevent adhesion recurrence.
Main Results:
- Viscero-parietal commissures (VPC) were identified in 1746 (76.7%) patients.
- Specialized ultrasonic examination demonstrated an average diagnostic value of 95.5%.
- Laparoscopic adhesiolysis was successful in 170 out of 195 (87.2%) patients with adhesive disease.
Conclusions:
- Laparoscopic surgery is associated with a high incidence of viscero-parietal commissures (VPC).
- Specialized ultrasonic examination is a highly effective diagnostic tool for VPC.
- Laparoscopic adhesiolysis is a successful treatment for adhesive disease, with Interceed (TC-7) showing potential for preventing recurrence.